NCT03052998View on ClinicalTrials.gov

Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy

PHASE4CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

December 31, 2017

Study Completion Date

August 1, 2018

Conditions
IvermectinOnchocerciasisEpilepsy
Interventions
DRUG

Ivermectin

Effect of Ivermectin on frequency of seizures

Trial Locations (1)

Unknown

Centre de Recherche en Maladies Tropicales de l'Ituri, Rethy

All Listed Sponsors
lead

Robert Colebunders

OTHER

NCT03052998 - Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy | Biotech Hunter | Biotech Hunter